LON:SBS - Source Bioscience Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous CloseN/A
Today's RangeN/A
52-Week RangeGBX 14 - GBX 19
VolumeN/A
Average Volume458,233 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Source BioScience plc is a provider of laboratory services and products to the healthcare and clinical, life and applied sciences and biopharmaceutical industries. The Company operates through two segments: Laboratory Services and Products. The Company's Laboratory Services segment consists of the laboratory and analytical testing activities of the Group including diagnostic testing for cancer and infectious disease; deoxyribonucleic acid (DNA) sequencing and contract research activities; stability and cryostorage in addition to analytical services, and stability testing. The Company's Products segment consists of portfolio of Clinical Products, including serology products for blood and tissue banking and liquid-based cytology products for cervical cancer screening, in addition to the portfolio of Life Science Research Reagents, including complementary DNA (cDNA) clones and other biomolecular tools, and controlled environment storage equipment and related servicing and validation.

Receive SBS News and Ratings via Email

Sign-up to receive the latest news and ratings for SBS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
CUSIPN/A
WebN/A
Phone+44-115-9739012

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
OptionableOptionable

Source Bioscience (LON:SBS) Frequently Asked Questions

What is Source Bioscience's stock symbol?

Source Bioscience trades on the London Stock Exchange (LON) under the ticker symbol "SBS."

Has Source Bioscience been receiving favorable news coverage?

Press coverage about SBS stock has been trending somewhat positive recently, InfoTrie Sentiment Analysis reports. The research group scores the sentiment of media coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Source Bioscience earned a media sentiment score of 1.4 on InfoTrie's scale. They also gave news stories about the company a news buzz of 1.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near term.

How do I buy shares of Source Bioscience?

Shares of SBS and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

How can I contact Source Bioscience?

Source Bioscience's mailing address is 1 Orchard Place Nottingham Business Park, NOTTINGHAM, NG8 6PX, United Kingdom. The company can be reached via phone at +44-115-9739012.


MarketBeat Community Rating for Source Bioscience (LON SBS)

Community Ranking:  1.8 out of 5 (star)
Outperform Votes:  53 (Vote Outperform)
Underperform Votes:  95 (Vote Underperform)
Total Votes:  148
MarketBeat's community ratings are surveys of what our community members think about Source Bioscience and other stocks. Vote "Outperform" if you believe SBS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SBS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel